A patient taking levothyroxine 100 µg daily has an elevated thyroid‑stimulating hormone (TSH) of 12.8 mIU/L; how should the levothyroxine dose be adjusted?

Management of Elevated TSH in a Patient on Levothyroxine

Increase the levothyroxine dose by 12.5 to 25 mcg daily and recheck TSH in 6-8 weeks. This patient has inadequate thyroid hormone replacement requiring dose adjustment to bring TSH into the normal reference range.

Immediate Action Required

Your patient's TSH of 12.81 mIU/L indicates subclinical hypothyroidism in a treated patient, which mandates dose adjustment 1. The FDA-approved approach is to titrate levothyroxine by 12.5 to 25 mcg increments every 4 to 6 weeks until the patient is euthyroid 2.

Before Adjusting the Dose

First, assess medication adherence and absorption issues 1:

• Poor compliance is the most common cause of persistently elevated TSH despite treatment 2, 3
• Malabsorption from gastrointestinal conditions (celiac disease, inflammatory bowel disease, atrophic gastritis) 2, 3
• Drug interactions that reduce levothyroxine absorption: iron supplements, calcium, proton pump inhibitors, bile acid sequestrants 2, 3
• Timing of administration: levothyroxine must be taken on an empty stomach, ideally 30-60 minutes before breakfast 2

If adherence and absorption are confirmed adequate, proceed with dose increase.

Dosing Strategy

Increase from 100 mcg to 112.5 or 125 mcg daily 2:

• The standard increment is 12.5 to 25 mcg 2
• Younger patients without cardiac disease can tolerate the full 25 mcg increase 2
• Elderly patients or those with cardiac disease should receive smaller increments (12.5 mcg) and slower titration every 6-8 weeks to avoid precipitating atrial fibrillation or angina 2, 3

Target TSH Range

Aim for TSH in the lower half of the normal reference range (0.4-2.5 mIU/L) 4:

• Guidelines recommend bringing TSH into the reference range for all treated hypothyroid patients 1
• Recent evidence shows increased mortality when TSH remains outside the normal range in either direction 5
• If the patient remains symptomatic with TSH in the upper half of normal, further dose adjustment to achieve TSH in the lower portion of the reference range is reasonable 1

Monitoring Timeline

Recheck TSH 6-8 weeks after dose adjustment 2:

• The peak therapeutic effect of levothyroxine takes 4 to 6 weeks to manifest due to its long half-life 2
• Earlier testing will not reflect steady-state levels and may lead to inappropriate dose changes 2
• Once stable, monitor TSH every 6-12 months 2

Special Considerations

If Patient is Pregnant or Planning Pregnancy

Increase dose immediately and monitor TSH every 4 weeks 1:

• Levothyroxine requirements increase by 25-50% during pregnancy 1
• Elevated TSH during pregnancy is associated with increased fetal wastage and neuropsychological complications in offspring 1
• Target TSH should be in the trimester-specific reference range 2

If Patient Has Cardiac Disease

Use smaller dose increments (12.5 mcg) and slower titration (every 6-8 weeks) 2:

• Even slight overreplacement increases risk of atrial fibrillation and osteoporotic fractures 6, 3
• Minimal TSH elevations may not require adjustment in patients with arrhythmias who feel well 1

Common Pitfalls to Avoid

Do not adjust dose more frequently than every 4-6 weeks 2:

• Premature dose changes before steady state is reached lead to overcorrection and cycling between hypo- and hyperthyroidism 2

Do not ignore persistently elevated TSH despite adequate dosing 2, 3:

• Inadequate response to doses >300 mcg/day suggests poor compliance, malabsorption, or drug interactions 2
• Consider supervised absorption testing if true malabsorption is suspected 7

Do not overtarget TSH suppression 5, 3:

• Overreplacement (TSH <0.4 mIU/L) increases mortality risk and should be avoided 5
• The goal is normalization, not suppression, unless treating thyroid cancer 2